Answers are grounded in this paper and cite their sources.
Evaluates efficacy and safety of inebilizumab in Chinese patients with NMOSD, highlighting its potential benefits.
This study aims to evaluate the efficacy and safety of inebilizumab in Chinese patients with AQP4 antibody-positive neuromyelitis optica spectrum disorder (NMOSD) through multicenter and large-sample data.
No takes yet. Share an insight, caveat, or question.
Gui et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: